Convergent Evolution: Shaping the import system of mitochondria
Mitochondria are organelles that fulfil a variety of critical functions in eukaryotic cells, and the event that resulted in their creation two billion years ago – when a bacterium fused with an ancient cell – was a defining moment in the evolution of life (Gray et al., 1999). However, the mitochondrial genome encodes a mere 13 different polypeptides, so the vast majority of the roughly 1500 mitochondrial proteins are made in the cytosol, and then imported into the organelle. These proteins are recognized and processed by various complexes which are embedded in the two membranes (the inner and outer mitochondrial membrane) that enclose a mitochondrion (Schmidt et al., 2010; Dolezal et al., 2006).
The import proteins present in the mitochondrial membranes can fold to form one of two structures: an α-helix or a β-barrel. How β-barrel proteins are taken into the mitochondrial outer membrane in the first place has been studied in much detail, and this process requires the translocase complex of the outer membrane, or TOM, to work with a structure called SAM (sorting and assembly machinery). The TOM complex is thought to be the main entrance for all mitochondrial proteins, irrespective of their final location within the organelle.
By contrast, it is less clear how α-helix proteins are brought to the outer membrane of mitochondria. However, several studies have suggested that, in fungi, a third ‘MIM’ (for mitochondrial import machinery) complex is involved (Figure 1; Becker et al., 2008). So far, it is known that Mim1 and Mim2 – the two proteins that form the MIM complex – are present in fungi but not in other eukaryotes.

Protein import complexes in mitochondria.
The outer mitochondrial membrane (OM) contains embedded protein complexes – such as the SAM, TOM and MIM complexes – that import proteins from the cytosol into the mitochondria. The SAM and TOM complexes interact to import β-barrel proteins (left). Certain subunits in the complexes (Tom22, Tom40 and Sam50) are highly conserved in all eukaryotes. However, the MIM complex, which imports α-helix proteins (right), is only present in fungi. Vitali et al. now show that pATOM36, an import protein found in the trypanosome T. brucei, and the MIM complex are functionally equivalent, despite their sequences being very different. This presents an exciting case of convergent evolution in a core protein import machinery of mitochondria. TOM: translocase complex of the outer membrane; SAM: sorting and assembly machinery; MIM: mitochondrial import machinery.
IMAGE CREDIT: Dr Afroditi Chatzi.
Biochemical and genome analyses of the TOM and SAM complexes across different organisms show that only a few subunits (Tom22, Tom40 and Sam50) are conserved in all eukaryotes. It is likely that the protein import system in the bacteria that became the modern mitochondria was made from these subunits. Other subunits are not conserved: for example, sequence analyses of two subunits of the TOM complex, Tom20 and Tom70, indicated that they evolved separately in fungi and plants. However, structural experiments showed that these subunits have adopted common structures that allow them to recognize and import mitochondrial proteins (Perry et al., 2006).
This was the first time a process known as convergent evolution – when species that are not related independently evolve similar structures to perform identical roles – had been observed in the mitochondrial import system. Further studies revealed that the trypanosome T. brucei also has receptors that have evolved separately from those in fungi and animals, but then converged to perform the same role (Mani et al., 2015). Now, in eLife, Doron Rapaport of the University of Tübingen, André Schneider of the University of Bern, and colleagues – Daniela Vitali, Sandro Käser and Antonia Kolb (as joint first authors), and Kai Dimmer – report another exciting example of convergent evolution, this time not for accessory receptor subunits but for a core import complex (Vitali et al., 2018).
In T. brucei, a protein called pATOM36 is found in the outer membrane of the mitochondria, where it helps to import other proteins. It is not related to the Mim1 receptor found in fungi, and their sequences are very dissimilar, but Vitali et al. have found that fungi in which the MIM complex has been replaced with pATOM36 can still import proteins. However, pATOM36 is not as effective as Mim1, possibly because it has evolved to prefer substrates that are only found in trypanosomes.
Likewise, Vitali et al. show that the MIM complex can take the place of pATOM36 in trypanosomes, providing that Mim1 and Mim2 are expressed at approximately the same levels. These largely unexpected results suggest that the MIM complex and pATOM36 perform their roles alone; indeed, it is unlikely that they could have found molecular partners to work with when placed in an unfamiliar environment.
How can MIM and pATOM36 replace each other when they are so distantly related? Both are embedded in the outer mitochondrial membrane, and are formed of several subunits, but the exact topology of pATOM36 is unknown. Structural analyses may provide important clues because a similarity in their structure could explain the overlap in their function. This would not be unprecedented; for example, proteins found in yeast mitochondria and bacteria fold into similar structures that allow them to bind to the same types of molecules (Alcock et al., 2008).
Another possibility is that MIM and pATOM36 have distinct structures that work in different ways but reach the same outcome – and attach to the same proteins. Again this would not be unprecedented; enzymes present in yeast and bacteria can use distinct mechanisms to create identical chemical links known as disulfide bonds in proteins (Riemer et al., 2009).
The work of Vitali et al. provides an intriguing hint that convergent evolution may have added components to the ancestral core import machinery in a modular way. In the future, biochemical, structural and genomics analyses of distant species could be combined to provide interesting clues, and maybe some surprises, about the evolution of the protein import systems of mitochondria. These answers may help us understand how an ancestral bacterium morphed into the organelle that powers most eukaryotic species today.
References
-
Biogenesis of the mitochondrial TOM complex: Mim1 promotes insertion and assembly of signal-anchored receptorsThe Journal of Biological Chemistry 283:120–127.https://doi.org/10.1074/jbc.M706997200
-
Mitochondrial protein import: from proteomics to functional mechanismsNature Reviews Molecular Cell Biology 11:655–667.https://doi.org/10.1038/nrm2959
Article and author information
Author details
Publication history
Copyright
© 2018, Tokatlidis
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,831
- views
-
- 230
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
Mutations in the kinase and juxtamembrane domains of the MET Receptor Tyrosine Kinase are responsible for oncogenesis in various cancers and can drive resistance to MET-directed treatments. Determining the most effective inhibitor for each mutational profile is a major challenge for MET-driven cancer treatment in precision medicine. Here, we used a deep mutational scan (DMS) of ~5764 MET kinase domain variants to profile the growth of each mutation against a panel of 11 inhibitors that are reported to target the MET kinase domain. We validate previously identified resistance mutations, pinpoint common resistance sites across type I, type II, and type I ½ inhibitors, unveil unique resistance and sensitizing mutations for each inhibitor, and verify non-cross-resistant sensitivities for type I and type II inhibitor pairs. We augment a protein language model with biophysical and chemical features to improve the predictive performance for inhibitor-treated datasets. Together, our study demonstrates a pooled experimental pipeline for identifying resistance mutations, provides a reference dictionary for mutations that are sensitized to specific therapies, and offers insights for future drug development.
-
- Biochemistry and Chemical Biology
- Genetics and Genomics
RNA binding proteins (RBPs) containing intrinsically disordered regions (IDRs) are present in diverse molecular complexes where they function as dynamic regulators. Their characteristics promote liquid-liquid phase separation (LLPS) and the formation of membraneless organelles such as stress granules and nucleoli. IDR-RBPs are particularly relevant in the nervous system and their dysfunction is associated with neurodegenerative diseases and brain tumor development. Serpine1 mRNA-binding protein 1 (SERBP1) is a unique member of this group, being mostly disordered and lacking canonical RNA-binding domains. We defined SERBP1’s interactome, uncovered novel roles in splicing, cell division and ribosomal biogenesis, and showed its participation in pathological stress granules and Tau aggregates in Alzheimer’s brains. SERBP1 preferentially interacts with other G-quadruplex (G4) binders, implicated in different stages of gene expression, suggesting that G4 binding is a critical component of SERBP1 function in different settings. Similarly, we identified important associations between SERBP1 and PARP1/polyADP-ribosylation (PARylation). SERBP1 interacts with PARP1 and its associated factors and influences PARylation. Moreover, protein complexes in which SERBP1 participates contain mostly PARylated proteins and PAR binders. Based on these results, we propose a feedback regulatory model in which SERBP1 influences PARP1 function and PARylation, while PARylation modulates SERBP1 functions and participation in regulatory complexes.